Treatment of staphylococcal disorders

Vectors for delivery of agents across biological membranes

Fatty acids and their use in conjugation to biomolecules

Therapeutic agent for fibroid lung

Methods of using ZSCAN4 for rejuvenating human cells

Methods and compositions for weed control

Methods and compositions related to T-cell activity

FALZ for use as a target for therapies to treat cancer

Sequence specific antimicrobials

Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules

Treatment of LCAT gene related diseases by inhibition of a natural antisense transcript to LCAT

Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene

TREATING TH2-MEDIATED DISEASES BY INHIBITION OF BROMODOMAINS

miRNA BIOGENESIS IN EXOSOMES FOR DIAGNOSIS AND THERAPY

Recombinant polypeptide production

Methods for including cardiomyocyte proliferation

Oligomers

Compositions and methods for inhibition of expression of protein C (PROC) genes

Methods for increasing efficacy of lipid formulated siRNA

Compositions And Methods For Inhibiting Expression Of GSK-3 Genes

Methods for monitoring C9ORF72 expression

LNA antisense oligonucleotides for the modulation of Myc expression

MiR-204 and miR-211 and uses thereof

miRNA for treating cancer and for use with adoptive immunotherapies

Polypeptide based block copolymer and the process for the preparation thereof, and the polymer micelles using the same

SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers

Method for treating muscle-invasive bladder cancer, containing S100A9 and EGFR inhibitors and cisplatin as active ingredients

MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT

Targeting microRNA miR-409-3P to treat prostate cancer

Serpinc1 iRNA compositions and methods of use thereof

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS (PMOS) AND THEIR USE IN SUPPRESSION OF MUTANT HUNTINGTIN EXPRESSION AND ATTENUATION OF NEUROTOXICITY

MICRORNAS AS FUNCTIONAL MEDIATORS AND BIOMARKERS OF BONE METASTASIS

Lipohillic oligonucleotide analogs

CHIMERIC OLIGOMERIC COMPOUNDS AND THEIR USE IN GENE MODULATION

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

Reducing intron retention

Method for expressing, secreting and transferring functional microRNAs/siRNAs and application thereof

Selective targeting of cancer stem cells

METHODS OF INCREASING INSULIN CONTENT IN CELLS

Lipid-Coated Albumin Nanoparticle Compositions and Methods of Making and Method of Using the Same

Method for enhancing a function of a T cell

Activation of innate immunity by miRNA for cancer and infection treatment

Methods and compositions for weed control

METHODS TO PREDICT AND PREVENT RESISTANCE TO TAXOID COMPOUNDS

Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP

Locked nucleic acid inhibitor of miR-145 and uses thereof

Bridged bicyclic nucleosides

Organic compositions to treat EPAS1-related diseases

Method for inhibiting tumor growth through RNA-interference using liposomally associated CDC20 siRNA

Method for treating and/or preventing myopia

OLIGOMERIC COMPOUNDS AND EXCIPIENTS

Biodegradable lipids for the delivery of active agents

Vectors and methods for genetic immunization

Immunomodulation by controlling expression levels of microRNAs in dendritic cells

Cell-penetrating oligonucleotides

Tetrary gene delivery system for gene therapy and methods of its use

MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION

Methods for co-silencing expression of genes in filamentous fungal strains and uses thereof

Compositions And Methods To Enhance Protein Expression

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

Multiple exon skipping compositions for DMD

ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

Multiple exon skipping compositions for DMD

Multiple exon skipping compositions for DMD

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same

Diagnostic and treatment for chronic and acute phase myeloid leukemia

METHODS AND COMPOSITIONS FOR MANAGING VASCULAR CONDITIONS

Compositions and methods for modulation of SMN2 splicing in a subject

TOX INHIBITION FOR THE TREATMENT OF CANCER

Cancer treatment

ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS

Notch inhibition in the prevention of vein graft failure

Nanoparticles stabilized with nitrophenylboronic acid compositions

Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions

Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

Method and compositions for the genetic control of insect pests in cotton plants by chitin synthase gene silencing

Promoter variants for expressing genes in a fungal cell

Selective antisense compounds and uses thereof

Modified oligonucleotides for telomerase inhibition

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

Multiple exon skipping compositions for DMD

Multiple exon skipping compositions for DMD

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations

Segmented micro RNA mimetics

CCCTC-Binding Factor (CTCF) RNA Interactome

Oligonucleotide

RNA Modification to Engineer Cas9 Activity

RNA Modification to Engineer Cas9 Activity

Treatment of metastatic tumors

Composition for gene delivery comprising chitosan and liquid crystal formation material

CELL LINES FOR VIRUS PRODUCTION AND METHODS OF USE

STABLE TRANSFORMATION OF A POPULATION AND A METHOD OF BIOCONTAINMENT USING HAPLOINSUFFICIENCY AND UNDERDOMINANCE PRINCIPLES

Treatment of neuropathic pain

Genetic control method and compositions against insect pests in cotton plants by the silencing of genes of the laccase family

COMPOSITIONS AND METHODS OF INHIBITING GENE EXPRESSION IN A LUNG

Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features

Compositions and methods for treating pancreatic cancer

TREATMENT OF INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1 (IFRD1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IFRD1

OLIGONUCLEOTIDES COMPRISING ALTERNATING SEGMENTS AND USES THEREOF

LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES

Methods to screen compounds for regulating USF1 activity and methods and compounds to treat cardiometabolic and lipid pathologies

ShRNA molecules and methods of use thereof

Intranuclear protein transduction through a nucleoside salvage pathway

Positively charged polysaccharides for RNA transfection

Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)

TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION

PLATELETS TRANSFECTED BY EXOGENOUS GENETIC MATERIAL AND PLATELET MICROPARTICLES OBTAINED BY SAID TRANSFECTED PLATELETS, METHOD FOR THE PREPARATION AND USES THEREOF

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

Inhibitors of miRNAs 221 and 222 for anti-tumor activity in multiple myeloma

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

Methods for treating eye disorders

Methods and compositions for targeting immunoglobulins

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin

Rotationally sequestered translators

Antisense antibacterial compounds and methods

Method of producing dicer

T cell balance gene expression, compositions of matters and methods of use thereof

INHIBITION OF THE COMPLEMENT SYSTEM

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES

Cancer antigen EEF2

Lipids, lipid complexes and use thereof

Technology for the Preparation of Microparticles

Methods, models, systems, and apparatus for identifying target sequences for Cas enzymes or CRISPR-Cas systems for target sequences and conveying results thereof

Diagnosing IDH1 related subgroups and treatment of cancer

MiRNA targets

Fertility gene and use thereof

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-beta

COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING

Methods of inhibiting proliferation of estrogen-independent cancer cells

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof

METHOD OF TREATING DELAYED HEALING OF A WOUND ASSOCIATED WITH DIABETES

COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR

Methods and compositions involving miRNA and miRNA inhibitor molecules

Method for diagnosis, prognosis and determination of treatment for cutaneous T-cell lymphoma

METHODS FOR CONTROLLING STEM CELL DIFFERENTIATION

Vectors and methods for genetic immunization

RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

Compositions and methods to promote bone formation

Methods and compositions involving miRNA and miRNA inhibitor molecules

Compositions and methods related to miRNA modulation of neovascularization or angiogenesis

Compounds and methods for modulating gene expression

Methods of trans-differentiating a terminally differentiated target cell to a neuron

INTRACELLULAR DELIVERY SYSTEM AND METHODS

Cationic lipid

Genetic Markers Associated with Degenerative Disc Disease and Uses Thereof

Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same

Methods and compositions to modulate RNA processing

Oligonucleotide compositions and methods of making the same

Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field

Splice modulating oligonucleotides that inhibit cancer

Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene

Methods and compositions for the production of siRNAs

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Methods and compositions for modulating apolipoprotein (a) expression

Biological control of coleopteran pests

ICAM-1 antisense for the treatment of inflammation and pain in a rectal stump

METHODS TO TREAT ALZHEIMER'S DISEASE USING APOE INHIBITORS

METHODS FOR TREATING INFLAMMATION

Inhibition of choroidal neovascularization

Biomarkers and treatments for heart failure

Analysis of nucleic acids associated with single cells using nucleic acid barcodes

Plant in which expression of a clathrin and/or coatomer subunit is suppressed or inhibited, a method for increasing the production of plant biomass and a method for producing a plant

Methods of treating ischemia-reperfusion injury with siRNAs

Gene Silencing by Single-Stranded Polynucleotides

MiRNA modulators of thermogenesis

GENE SILENCING

SELECTIVE REDUCTION OF ALLELIC VARIANTS

LONG NON-CODING RNA USED FOR ANTICANCER THERAPY

RNA INTERFERENCE TO ACTIVATE STEM CELLS

IDENTIFICATION AND USE OF NEW TUMOR-PROMOTING GENE IN HEMATOLOGICAL MALIGNANCIES

SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTATIS

Molecular signatures of ovarian cancer

Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies

Nucleic acid molecules that confer resistance to coleopteran pests

SEC23 NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS

Modified oligonucleotides for telomerase inhibition

Modified oligonucleotides for telomerase inhibition

Oligomeric compounds and compositions for the use in modulation of micrornas

Formulations for treating amyloidosis

INDUCTION OF EXON SKIPPING IN EUKARYOTIC CELLS

Post-synthetic orthogonal amidation plus metal catalyzed azide-alkyne cycloaddition click chemistry on siRNA

Compositions and methods for functional nucleic acid delivery

Methods and compositions of improved modified siRNA

Treatment of B-cell lymphoma with microRNA

SNPs OF APOLIPOPROTEIN B AND MODULATION OF THEIR EXPRESSION

COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS

Cancer treatment and immune system regulation through FAT10 pathway inhibition

Production of therapeutic proteins in genetically modified mammalian cells

Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy

Identification of an inhibitor of iRhom1 or an inhibitor of iRhom2

Mantle phenotype detection in palm

Transferrin/transferrin receptor-mediated siRNA delivery

NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF

Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome

Methods of inhibiting cancer stem cells with HMGA1 inhibitors

Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers

Multimeric oligonucleotides compounds having cleavable linkers

METHODS OF DELIVERING MULTIPLE TARGETING OLIGONUCLEOTIDES TO A CELL USING NON-NUCLEOTIDE BASED CLEAVABLE LINKERS

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

Compositions and methods for silencing apolipoprotein C-III expression

Methods and compositions for the specific inhibition of CKAP5 by double-stranded RNA

Deep intronic target for splicing correction on spinal muscular atrophy gene

Signal activatable constructs and related components compositions methods and systems

COMPOUNDS AND METHODS FOR IMPROVING CELLULAR UPTAKE OF OLIGOMERIC COMPOUNDS

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Identification of novel genes coding for small temporal RNAs

Method for inhibiting calcification of a macrophage-derived matrix vesicle

GENETIC DEVICE FOR THE CONTROLLED DESTRUCTION OF DNA

Compositions and methods for selective delivery of oligonucleotide molecules to cell types

Production of stable non-polyadenylated RNAs

Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation

Disulfide masked prodrug compositions and methods

Compositions and methods for polynucleotide transfection

Amphipathic peptide

Composition and method for treating a hematological malignancy

Treatment-induced damage to the tumor micro-environment promotes cancer therapy resistance through extracellular proteins

ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME

RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

UNA OLIGOMERS HAVING REDUCED OFF-TARGET EFFECTS IN GENE SILENCING

Transthyretin allele selective UNA oligomers for gene silencing

ANOIKIS RESISTANT PLACENTAL STEM CELLS AND USES THEREOF

RNA interference agent, method for producing same, and use therefor

Compositions and their uses directed to huntingtin

DNA ASSIMILATION

Reprogramming of human whartons jelly cells to produce hair cells

Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof

miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

Treatment of human cytomegalovirus by modulating Wnt

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

Genetic alterations on chromosomes 21Q, 6Q and 15Q and methods of use thereof for the diagnosis and treatment of type 1 diabetes

Competitive modulation of microRNAs

Transgenic plants with modified sugar content and methods of generating same

Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

Methods for treatment of alport syndrome

In vivo gene silencing by chemically modified and stable siRNA

CIRCULAR RNA FOR INHIBITION OF MICRORNA

Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor

EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USES THEREOF

MICROMIRs

METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES

Compositions and methods for inhibiting hypdxia induced damage

SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS

Multimeric oligonucleotides compounds

In vitro production of DNA minicircles comprising less than 250 base pairs

Compositions and methods for inhibiting viral entry

MODULATION OF RENIN-ANGIOTENSIN SYSTEM (RAS) RELATED DISEASES BY ANGIOTENSINOGEN

Methods for treating renal disease

Animal models of neurological disorders

Treatment of angiogenesis disorders

Extraction, preparation, and application of plant micro-ribonucleic acid

RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX

MODULATION OF CD40 EXPRESSION

Diagnosis and treatment of endometriosis

ANTI APOB ANTISENSE CONJUGATE COMPOUNDS

METHODS AND COMPOSITIONS TO PRODUCE ss-RNAi ACTIVITY WITH ENHANCED POTENCY

RNA TARGETED TO BETA CATENIN

Antisense compounds targeting genes associated with fibronectin

Organic compositions to treat beta-catenin-related diseases

Exosome transfer of nucleic acids to cells

Short interference RNA gene delivery system for systemic circulation

ARTIFICIAL DNA SEQUENCE WITH OPTIMIZED LEADER FUNCTION IN 5' (5'-UTR) FOR THE IMPROVED EXPRESSION OF HETEROLOGOUS PROTEINS IN PLANTS

Reducing levels of nicotinic alkaloids in plants

Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)

Methods and compositions for use in treatment of FOXP2-related cancers

Organic compositions to treat HSF1-related diseases

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

miRNA169 compositions and methods for the regulation of carbohydrate metabolism and flowering in plants

Therapeutics with conformationally restricted monomers

Oligonucleotide complex compositions and methods of use as gene alteration tools

Poly(vinyl ester) polymers for in vivo nucleic acid delivery

Polymeric nanoparticles

MiRNAs as novel therapeutic targets and diagnostic biomarkers for parkinsons disease

Method for establishing modified host cell

RIG-I ligands and methods for producing them

Delivery of dsRNA to arthropods

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

Oligonucleotide conjugates

ANTISENSE COMPOUNDS AND USES THEREOF

Inhibiting migration of cancer cells

COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY

SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF

COMPOSITIONS AND METHODS FOR MODULATING POLYPEPTIDE LOCALIZATION IN PLANTS

POLYMER CONJUGATES FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS

Methods for modulating Tau expression for reducing seizure and modifying a neurodegenerative syndrome